Vestmark Advisory Solutions Inc. Grows Position in Exponent, Inc. (NASDAQ:EXPO)

Vestmark Advisory Solutions Inc. raised its position in Exponent, Inc. (NASDAQ:EXPOFree Report) by 2.6% during the fourth quarter, HoldingsChannel.com reports. The firm owned 32,184 shares of the business services provider’s stock after purchasing an additional 809 shares during the period. Vestmark Advisory Solutions Inc.’s holdings in Exponent were worth $2,834,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Kayne Anderson Rudnick Investment Management LLC lifted its position in shares of Exponent by 9.5% during the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 4,685,472 shares of the business services provider’s stock worth $401,076,000 after purchasing an additional 408,295 shares during the last quarter. Conestoga Capital Advisors LLC boosted its position in Exponent by 0.3% in the 4th quarter. Conestoga Capital Advisors LLC now owns 2,451,301 shares of the business services provider’s stock valued at $215,813,000 after buying an additional 7,032 shares during the period. Ameriprise Financial Inc. grew its stake in Exponent by 11.4% in the 3rd quarter. Ameriprise Financial Inc. now owns 693,259 shares of the business services provider’s stock worth $59,343,000 after acquiring an additional 71,074 shares in the last quarter. Invesco Ltd. increased its position in shares of Exponent by 89.4% during the third quarter. Invesco Ltd. now owns 594,343 shares of the business services provider’s stock worth $50,876,000 after acquiring an additional 280,600 shares during the period. Finally, Raymond James & Associates raised its stake in shares of Exponent by 2.1% during the third quarter. Raymond James & Associates now owns 484,488 shares of the business services provider’s stock valued at $41,472,000 after acquiring an additional 10,046 shares in the last quarter. 92.37% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on EXPO shares. StockNews.com raised Exponent from a “sell” rating to a “hold” rating in a research note on Monday, March 4th. Truist Financial boosted their price objective on shares of Exponent from $95.00 to $100.00 and gave the stock a “buy” rating in a research note on Monday, April 29th.

Get Our Latest Stock Analysis on Exponent

Exponent Stock Performance

NASDAQ:EXPO traded up $1.91 during mid-day trading on Friday, hitting $94.33. 218,679 shares of the company’s stock traded hands, compared to its average volume of 303,196. The company has a market capitalization of $4.78 billion, a P/E ratio of 47.64 and a beta of 0.64. The company has a fifty day moving average of $81.47 and a 200 day moving average of $82.00. Exponent, Inc. has a twelve month low of $64.61 and a twelve month high of $102.72.

Exponent (NASDAQ:EXPOGet Free Report) last announced its quarterly earnings data on Thursday, April 25th. The business services provider reported $0.59 EPS for the quarter, beating the consensus estimate of $0.46 by $0.13. The firm had revenue of $137.21 million during the quarter, compared to analyst estimates of $125.98 million. Exponent had a net margin of 18.72% and a return on equity of 28.13%. Exponent’s revenue was up 6.6% on a year-over-year basis. During the same period last year, the firm posted $0.56 EPS. On average, research analysts expect that Exponent, Inc. will post 1.92 earnings per share for the current fiscal year.

Exponent Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 21st. Stockholders of record on Friday, June 7th will be issued a dividend of $0.28 per share. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.19%. The ex-dividend date is Friday, June 7th. Exponent’s dividend payout ratio (DPR) is presently 56.57%.

Insider Activity at Exponent

In other news, insider Eric Guyer sold 1,650 shares of the firm’s stock in a transaction that occurred on Tuesday, April 30th. The stock was sold at an average price of $92.58, for a total value of $152,757.00. Following the transaction, the insider now owns 1,846 shares in the company, valued at $170,902.68. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders have sold a total of 5,030 shares of company stock valued at $418,242 in the last ninety days. Company insiders own 2.20% of the company’s stock.

Exponent Profile

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Further Reading

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPOFree Report).

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.